corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 12056

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Krauskopf L, Grant J.
Pfizer wins ruling that may limit Celebrex lawsuits
Reuters 2007 Nov 20
http://www.reuters.com/article/healthNews/idUSN2054066520071120


Full text:

Pfizer Inc has won a U.S. court ruling that could limit lawsuits alleging its painkiller Celebrex caused heart attacks and strokes.

Judge Charles Breyer of U.S. district court for the Northern District of California ruled on Monday that plaintiffs have not presented “scientifically reliable evidence” that Celebrex causes heart attacks or strokes when taken at a strength of 200 milligrams, according to court documents.

Most Celebrex patients are prescribed the 200 mg dosage, according to Pfizer.

More than 3,000 plaintiffs have claimed Celebrex caused heart problems, in federal lawsuits against the drug maker.

“We are pleased with the decision of the federal court which recognizes the lack of any credible evidence linking Celebrex, at its most common dosage form, with heart attacks or strokes,” Pfizer general counsel Allen Waxman said in a statement.

“We believe that this ruling will greatly limit the scope of this litigation, and we intend to continue to vigorously defend the cases against us,” Waxman said.

Celebrex is part of the Cox-2 class of painkillers, which includes two drugs no longer on the market: Merck & Co’s Vioxx and Pfizer’s Bextra.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.